Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06482957

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,100 (estimated)
Sponsor
Vanderbilt-Ingram Cancer Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

Detailed description

* To evaluate the incidence and prevalence and the impact of disease, treatment, sociodemographic and lifestyle contributors on adverse oncologic outcomes (lack of response, recurrence) and non- oncologic outcomes (physical and psychosocial function, financial toxicity, short and long-term organ toxicity) and mortality in the cohort. * To evaluate the role of drug metabolism and DNA repair genes via functional polymorphisms, known toxicity associated polymorphisms and genetically predicted gene expression levels, as well as polygenic risk scores, on treatment efficacy, cancer therapy-induced normal tissue toxicity and mortality. * To identify genomic drivers of sarcoma and to use this information to develop personalized liquid biopsy assays for monitoring treatment response, recurrence, and minimal residual disease (MRD) and mortality. * Evaluate family functioning, psychosocial wellbeing, and financial toxicity. OUTLINE: This is an observational study. Patients monitor physical activity, sedentary behavior, heart rate and sleep wearing a FitBit device, undergo blood urine, stool and/or saliva sample collection, complete surveys and have medical records reviewed throughout study.

Conditions

Interventions

TypeNameDescription
OTHERSurveysComplete surveys
OTHERBlood CollectionUndergo blood collection
OTHERSaliva CollectionUndergo salvia collection
OTHERUrine CollectionUndergo urine collection
OTHERStool CollectionUndergo stool collection
OTHERTissue collectionUndergo tissue collection
OTHERPhysical Activity MonitoringFitBit will be worn to track physical activity

Timeline

Start date
2022-04-01
Primary completion
2028-04-01
Completion
2029-04-01
First posted
2024-07-01
Last updated
2025-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06482957. Inclusion in this directory is not an endorsement.